2017
DOI: 10.1016/j.actbio.2016.10.013
|View full text |Cite
|
Sign up to set email alerts
|

Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
69
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 91 publications
(74 citation statements)
references
References 36 publications
4
69
0
Order By: Relevance
“…Lee et al immobilized NGF into fibrin scaffolds in order to substantially improve nerve regeneration in a rat sciatic injury model (Lee et al, ). The PEG‐Fib materials have also been endowed and tested ex vivo with NGF (Berkovitch & Seliktar, ; Sarig‐Nadir & Seliktar, , ) and in vivo with other growth factors for other indications (Berdichevski, Simaan Yameen, Dafni, Neeman, & Seliktar, ; Rufaihah et al, ; Rufaihah et al, ); however, a comprehensive in vivo study of PEG‐Fib with NGF for nerve injuries is warranted as part of our future validation of this strategy.…”
Section: Resultsmentioning
confidence: 99%
“…Lee et al immobilized NGF into fibrin scaffolds in order to substantially improve nerve regeneration in a rat sciatic injury model (Lee et al, ). The PEG‐Fib materials have also been endowed and tested ex vivo with NGF (Berkovitch & Seliktar, ; Sarig‐Nadir & Seliktar, , ) and in vivo with other growth factors for other indications (Berdichevski, Simaan Yameen, Dafni, Neeman, & Seliktar, ; Rufaihah et al, ; Rufaihah et al, ); however, a comprehensive in vivo study of PEG‐Fib with NGF for nerve injuries is warranted as part of our future validation of this strategy.…”
Section: Resultsmentioning
confidence: 99%
“…The myocardial thickness and the density blood vessels of the rat myocardial infarction model were larger than that of the group without treating, following the injection of a novel temperature-susceptible aliphatic polyester hydrogel (HG) crosslinked with VEGF (Wu et al, 2011). Retention of highly vascularized cardiomyocytes is a limiting factor in growth factor therapy although it presents superior performance in cardiovascular repair (Rufaihah et al, 2017). The Dex-PCL-HEMA/PNIPAAm hydrogelcon containing VEGF developed by Zhu et al (2016) and the injectable hydrogel amalgamated polyethylene glycol with fibrinogen (PEG-fibrinogen) loaded with VEGF-A designed by Rufaihah et al (2013) both are able to release and store VEGF in a controlled manner and achieve better cardiac repair than VEGF alone.…”
Section: Cell Active Factormentioning
confidence: 99%
“…The Dex-PCL-HEMA/PNIPAAm hydrogelcon containing VEGF developed by Zhu et al (2016) and the injectable hydrogel amalgamated polyethylene glycol with fibrinogen (PEG-fibrinogen) loaded with VEGF-A designed by Rufaihah et al (2013) both are able to release and store VEGF in a controlled manner and achieve better cardiac repair than VEGF alone. Moreover, in order to present a superior repair effect, an polyethylene glycol-fibrinogen (PF) hydrogels was manufactured for sustained dual transportation of VEGF and angiopoietin-1 (ANG-1) to promote myocardial therapy (Rufaihah et al, 2017). Recently, researchers' research hotspots have shifted from the development of nano-growth factor injectable hydrogels to exploring which nano-growth factor injectable hydrogel complexes present superior cardiac repair functions.…”
Section: Cell Active Factormentioning
confidence: 99%
See 1 more Smart Citation
“…[12][13][14][15] These drug releasing systems share the similar principle that drugs loaded in the inner layer are released more slowly than those in the outer layer. In addition, the drugs themselves can affect releasing dynamics due to the differences of drug structure, hydrophilia and molecular weight, [16][17][18] which consequently lead to phased drug release. As a result, the drug releasing models can be regulated to meet multiple clinical demands.…”
Section: Introductionmentioning
confidence: 99%